Skip to main content
Clinical Trials/DRKS00027078
DRKS00027078
Recruiting
Not Applicable

Analysis of the correlation of serum-biomarker based measures of neurodegeneration and synaptic dysfunction with outcome in patients with delirium and acute encephalopathy

Institut für Klinische Chemie, Haus U30und Klinik für Neurologie, Haus DUniverstitätsklinikum Schleswig-Holstein0 sites40 target enrollmentNovember 8, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
F05.0
Sponsor
Institut für Klinische Chemie, Haus U30und Klinik für Neurologie, Haus DUniverstitätsklinikum Schleswig-Holstein
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 8, 2021
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Institut für Klinische Chemie, Haus U30und Klinik für Neurologie, Haus DUniverstitätsklinikum Schleswig-Holstein

Eligibility Criteria

Inclusion Criteria

  • Delirium: Age \>\= 18 years, Patient or legal representative gave consent, clinical diagnosis of delirium or acute encephalopathy, screened by CAM\-ICU and validated by ICD\-10 criteria
  • Controls: Age \>\= 18 years, Patient or legal representative gave consent

Exclusion Criteria

  • Documented history of dementia, history of intracranial and cardiovascular surgery or recent interfering neurological events within the past year, including stroke, trauma, encephalitis, brain metastasis and seizures

Outcomes

Primary Outcomes

Not specified

Similar Trials